Chemical Sterilization Equipment Market Size, Share, Growth, and Industry Analysis, By Types (Ethylene Oxide Sterilization,Hydrogen Peroxide Sterilization,Ozone-based Sterilization,Formaldehyde Sterilization,Others), By Applications Covered (Hospitals & Clinics,Medical Equipment and Consumables,Pharmaceutical,Food & Beverage Industry,Others), Regional Insights and Forecast to 2035
- Last Updated: 23-October-2026
- Base Year: 2025
- Historical Data: -
- Region: Global
- Format: PDF
- Report ID: GGI114685
- SKU ID: 29561207
- Pages: 96
Download FREE Sample
Chemical Sterilization Equipment Market Size
The Global Chemical Sterilization Equipment Market was valued at USD 1.52 Billion in 2025 and is projected to reach USD 1.62 Billion in 2026 and USD 1.73 Billion in 2027, before reaching USD 2.90 Billion by 2035, exhibiting a CAGR of 6.7% during the forecast period from 2026 to 2035. Market expansion reflects increasing demand for dependable sterilization processes, the growing use of heat-sensitive medical instruments, and the need for consistent microbial control across healthcare and pharmaceutical operations.
The Chemical Sterilization Equipment Market is evolving as healthcare providers and industrial users prioritize process reliability, instrument compatibility, and documented sterilization outcomes. Ethylene oxide and hydrogen peroxide technologies remain important because they can treat selected materials that cannot withstand conventional high-temperature processing. Hydrogen peroxide-based systems are gaining attention for their suitability in specialized low-temperature applications, while ethylene oxide continues to serve applications requiring deep penetration into compatible medical devices and packaging. Equipment purchasing decisions increasingly consider cycle validation, operator protection, ventilation requirements, consumable availability, and lifecycle costs. Facilities are also evaluating automated controls and digital records to improve repeatability. As procurement becomes more quality-focused, equipment manufacturers that combine validated performance with efficient workflows are better positioned to address demand. An illustrative planning assumption is that low-temperature processes could account for approximately 55% of new equipment evaluations in settings with substantial heat-sensitive instrument requirements, although the actual proportion varies by facility and product mix.
![]()
In the US Chemical Sterilization Equipment Market, demand is supported by established hospital infrastructure, stringent infection-prevention practices, and continued use of complex reusable medical devices. Healthcare systems are evaluating equipment that supports traceability, standardized cycles, and safer handling of sterilizing agents. Hydrogen peroxide systems are particularly relevant for compatible heat-sensitive instruments, while ethylene oxide remains important for selected device-manufacturing applications. As an indicative operational benchmark rather than a measured national statistic, facilities may target a 10% to 15% reduction in avoidable instrument-processing delays through better scheduling, equipment utilization, and monitoring. Purchasing priorities nevertheless differ between large hospital networks, ambulatory facilities, pharmaceutical manufacturers, and contract sterilization providers.
Key Findings
- Sta rting at USD 1.62 Billion in 2026, the global Chemical Sterilization Equipment Market is projected to reach USD 1.73 Billion in 2027 and USD 2.90 Billion by 2035. The market is expected to expand at a CAGR of 6.7% throughout the forecast period from 2026 to 2035, supported by increasing sterilization requirements across healthcare, medical device manufacturing, pharmaceutical production, and other contamination-sensitive operations.
- Demand for chemical sterilization equipment is increasing as healthcare facilities process larger volumes of heat-sensitive and complex reusable instruments. Hospitals & clinics account for approximately 35% of the application mix, while medical equipment and consumables represent nearly 30%. Growing emphasis on infection prevention, standardized processing, instrument compatibility, and reliable low-temperature sterilization continues to influence equipment procurement.
- Chemical sterilization equipment plays an important role where conventional high-temperature processing is unsuitable for sensitive materials and device configurations. Ethylene oxide sterilization represents approximately 40% of the modeled technology mix, while hydrogen peroxide sterilization accounts for nearly 35%. These technologies remain important because equipment selection increasingly depends on penetration requirements, material compatibility, cycle validation, operator safety, and processing efficiency.
- Growth in automated sterilization controls, electronic process records, cycle monitoring, and equipment modernization is strengthening the market outlook. Approximately 25% of an illustrative technology investment allocation is associated with automation and monitoring capabilities, while around 20% can be directed toward service and validation infrastructure. Manufacturers are consequently emphasizing equipment reliability, simplified operation, traceability, preventive maintenance, and application-specific sterilization cycles.
- North America accounts for approximately 32% of the modeled global Chemical Sterilization Equipment Market, supported by established healthcare infrastructure and medical device manufacturing. Asia-Pacific represents about 31%, driven by expanding healthcare capacity and pharmaceutical and medical equipment production. Europe holds nearly 27%, while the Middle East & Africa accounts for approximately 10%, bringing the four regional shares to 100%.
The market's comm ercial direction is influenced by the need to reconcile sterilization effectiveness with operating efficiency. Facilities that process diverse instruments must select technologies according to validated device compatibility rather than cycle speed alone. A modeled 55% share for low-temperature technology in selected new-equipment evaluations illustrates the potential importance of heat-sensitive applications, not an established global shipment statistic. Procurement teams should compare documented product compatibility, throughput, maintenance support, and operating requirements before selecting a system. Another defining consideration is the relationship between equipment investment and process assurance. Improved monitoring can support more consistent documentation, but digital records do not independently establish sterility. Qualification, validated cycles, appropriate indicators, trained operators, and adherence to the device manufacturer's instructions remain essential. Manufacturers that combine reliable equipment with accessible technical support and clear validation documentation can strengthen their position in quality-sensitive purchasing environments.
Chemical Sterilization Equipment Market Trends
The Chemical Sterilization Equipment Market is moving toward more application-specific low-temperature processing, reflecting the expanding variety of reusable instruments and materials that cannot tolerate conventional heat-intensive methods. Hydrogen peroxide-based equipment is relevant to compatible endoscopes, surgical instruments, and selected medical devices, while ethylene oxide continues to be used for products whose construction or packaging requires its penetration characteristics. Ozone-based and formaldehyde-based approaches serve more specialized settings, with adoption influenced by process validation, material compatibility, exposure controls, and local requirements. Rather than replacing one technology universally, facilities are increasingly evaluating combinations of methods to match different product families. In a planning scenario, low-temperature systems could represent approximately 55% of equipment evaluations in instrument-intensive facilities, while the remaining demand would depend on product mix and established processing infrastructure. This illustrative estimate should not be interpreted as a verified market-wide share.
Automation and data traceability are also becoming important differentiators. Buyers are looking for programmable cycles, clear alarms, accessible maintenance information, electronic batch records, and interfaces that support equipment oversight. These capabilities can help staff identify process deviations and reduce avoidable administrative work, provided the systems are properly validated and maintained. Sustainability considerations are encouraging scrutiny of sterilant consumption, energy requirements, water use, packaging compatibility, and ventilation needs. However, environmental performance must be assessed alongside microbial efficacy and worker safety rather than treated as a substitute for validated processing. A practical procurement objective is to reduce avoidable reprocessing and documentation-related delays by 10% to 15% through improved workflows; actual outcomes will vary according to baseline performance, staff training, and the instruments being processed. The wider trend therefore favors equipment that combines application-specific effectiveness, reliable monitoring, maintainability, and a manageable operating burden.
Chemical Sterilization Equipment Market Dynamics
Expansion of low-temperature sterilization applications
The growing diversity of heat-sensitive instruments creates opportunities for equipment that supports validated processing at lower temperatures. Hospitals, device manufacturers, and specialized laboratories may evaluate hydrogen peroxide or other compatible chemical methods when conventional heat would damage materials or affect functionality. Product compatibility, lumen configuration, packaging, and validated cycle claims determine whether a technology is appropriate. An illustrative procurement objective is to reduce avoidable instrument-processing delays by 10% to 15% through better cycle selection and scheduling. Suppliers that provide application assessments, validation support, staff training, and dependable servicing can help customers translate technology improvements into practical operational benefits.
Higher expectations for infection prevention and process assurance
Healthcare providers and medical device manufacturers require repeatable processes supported by appropriate validation, monitoring, and documentation. Equipment upgrades can help address inconsistent workflows, changing instrument designs, and growing demands for traceability. The strongest business case often combines dependable sterilization with manageable cycle times, maintenance access, and operator protection. Facilities may use a 10% to 15% reduction in avoidable processing delays as an internal performance objective, although this is not a guaranteed result. Purchasing decisions continue to depend on clinical requirements, regulatory obligations, equipment utilization, and the suitability of the chosen sterilization method for each product.
| Market Driver | Impact Rank | Contribution | 2026-2028 | 2029-2031 | 2032-2035 |
|---|---|---|---|---|---|
| Rising infection-prevention requirements and demand for validated sterilization processes | High | 2.35% | High | High | High |
| Growing use of heat-sensitive and complex reusable medical instruments | High | 1.95% | High | High | High |
| Expansion of pharmaceutical and medical device manufacturing capacity | Medium | 1.65% | Medium | High | High |
| Increasing adoption of automated monitoring, traceability, and digital cycle controls | Medium | 1.40% | Medium | High | High |
| Replacement and modernization of aging sterilization infrastructure | Low | 1.15% | Medium | Medium | High |
| Others | Lowest | 0.70% | Low | Medium | Medium |
| Total Driver Contribution | 9.20% |
Market Restraints
"High installation and compliance requirements"
Chemical sterilization equipment can require specialized installation, environmental controls, staff training, process qualification, and ongoing maintenance. Ethylene oxide installations may involve additional ventilation, exposure monitoring, and emissions-control considerations, while hydrogen peroxide systems require suitable material compatibility and validated cycle parameters. These requirements can make implementation difficult for smaller hospitals and facilities with limited engineering resources. Procurement teams must consider the entire operating model, including sterilant storage, consumables, service contracts, validation documentation, and equipment downtime. A modeled 10% to 15% reduction in avoidable delays may be a useful internal target, but savings can be offset when qualification work or instrument compatibility issues are underestimated. Careful planning is therefore essential before installation or technology replacement.
| Market Restraint | Impact Rank | Negative CAGR Impact | 2026-2028 | 2029-2031 | 2032-2035 |
|---|---|---|---|---|---|
| High installation, qualification, validation, and lifecycle compliance costs | High | -1.05% | High | High | Medium |
| Strict sterilant handling, emissions control, and occupational safety requirements | Medium | -0.70% | High | Medium | Medium |
| Material compatibility limitations and complexity of validating diverse medical devices | Low | -0.45% | Medium | Medium | Low |
| Others | Lowest | -0.30% | Low | Low | Low |
| Total Restraint Impact | -2.50% |
Market Challenges
"Balancing throughput, material compatibility, and operator safety"
Manufacturers must design systems that deliver reliable sterilization without damaging delicate materials, restricting instrument availability, or creating unnecessary operator exposure. Different technologies cannot be treated as interchangeable because cycle parameters, penetration characteristics, packaging requirements, and residual considerations vary. Hospitals may also process instruments with different configurations, making loading practices and validated instructions important to consistent results. Equipment providers must address usability, maintenance access, alarm interpretation, and staff competency while keeping operating requirements manageable. A facility may set an internal objective of reducing processing-related delays by 10%, but achieving that result requires coordination across instrument inventory, cleaning, packaging, sterilization, release, and distribution. Poor coordination in any stage can weaken the benefits of an advanced sterilizer.
Segmentation Analysis
The Chemical Sterilization Equipment Market is segmented by sterilization technology and end-use application. Technology selection depends on microbial inactivation requirements, temperature sensitivity, material construction, device geometry, packaging, and process validation. Application demand varies between healthcare facilities processing reusable instruments and manufacturers treating medical products before distribution. The five technology categories considered are ethylene oxide sterilization, hydrogen peroxide sterilization, ozone-based sterilization, formaldehyde sterilization, and others. The application categories include hospitals and clinics, medical equipment and consumables, pharmaceutical, food and beverage industry, and others. Hydrogen peroxide is particularly relevant to compatible heat-sensitive instruments, whereas ethylene oxide serves selected products requiring gas penetration. No single method is suitable for every device or product category.
By Type
Ethylene Oxide Sterilization
Ethylene oxide sterilization remains important for compatible medical devices with intricate geometries, narrow passages, and packaging configurations that require gas penetration. Its applications include selected single-use medical products and components that cannot withstand conventional heat or moisture. Equipment design must address controlled gas exposure, aeration, monitoring, worker protection, and emissions management. Buyers assess the complete cycle rather than exposure time alone because aeration and validated release requirements affect throughput. For planning purposes, ethylene oxide could represent approximately 40% of demand across a modeled mix of chemical sterilization equipment technologies, although this is an illustrative assumption rather than a verified market share. Regulatory scrutiny and operating complexity encourage facilities to evaluate whether alternative technologies are suitable for specific products.
Hydrogen Peroxide Sterilization
Hydrogen peroxide sterilization is increasingly relevant to compatible heat-sensitive surgical instruments, endoscopes, and specialized medical devices. Vaporized hydrogen peroxide and related systems can support low-temperature processing when the product, packaging, and instrument configuration are covered by validated cycle requirements. The technology attracts interest because properly controlled processes can provide relatively short cycles for suitable loads and may leave water and oxygen as principal decomposition products. Nevertheless, material compatibility, lumen restrictions, moisture, load preparation, and manufacturer instructions remain decisive. An illustrative planning assumption assigns approximately 35% of modeled technology demand to hydrogen peroxide systems. This figure is not a measured global share; actual adoption depends on healthcare infrastructure, instrument mix, installed equipment, and local approval requirements.
Ozone-based Sterilization
Ozone-based sterilization uses the oxidative properties of ozone under controlled process conditions to inactivate microorganisms on compatible products. Equipment selection depends on the ability to maintain validated exposure conditions and demonstrate performance across the intended load configuration. Facilities must also consider ozone containment, monitoring, material compatibility, and the safe management of process by-products. The technology may be evaluated where users seek alternatives to established chemical sterilization methods, but adoption depends on application-specific evidence and regulatory acceptance. A planning scenario could assign approximately 10% of modeled technology demand to ozone-based equipment, subject to substantial variation between healthcare, laboratory, and industrial settings. This estimate is illustrative rather than a verified market statistic. Buyers should confirm that the specific device and sterilization claim are supported by applicable validation evidence.
Formaldehyde Sterilization
Formaldehyde-based sterilization has historically served selected controlled environments and applications requiring low-temperature processing. Its use is influenced by exposure controls, residual management, material compatibility, and applicable occupational and environmental requirements. Facilities considering this method must evaluate the complete equipment configuration, including containment, ventilation, monitoring, and the procedures required to protect operators. Procurement decisions may increasingly favor other validated methods where they provide a more suitable balance of safety, compatibility, and workflow efficiency. An illustrative planning allocation places formaldehyde equipment at approximately 5% of the modeled technology mix, but this should not be interpreted as a measured global share. Continued demand is expected to depend heavily on specific installed systems, application requirements, and local regulatory conditions.
Others
The other category includes specialized chemical sterilization approaches that do not fall within the four principal categories identified above. Demand may originate from laboratories, specialized manufacturing environments, and facilities with particular material or process requirements. Equipment developers must demonstrate repeatable microbial inactivation, safe operation, and compatibility with the intended product rather than relying solely on the general properties of a sterilant. Purchasing teams also examine process documentation, maintenance support, and the availability of qualified consumables. A modeled allocation of approximately 10% for other technologies completes the illustrative technology mix. The actual share will vary by the market definition, geographic coverage, and treatment of specialized systems. Emerging technologies will need robust validation and practical operational advantages to achieve wider adoption.
By Application
Hospitals & Clinics
Hospitals and clinics require sterilization equipment to support surgical services, reusable instrument processing, endoscopy, and other procedures that depend on appropriate infection prevention. Low-temperature chemical systems are valuable for compatible heat-sensitive devices, while centralized sterile-processing departments need predictable cycle performance and dependable equipment availability. Capacity planning considers procedure volumes, instrument turnaround, loading patterns, and maintenance schedules. An illustrative assumption is that hospitals and clinics account for approximately 35% of the modeled application mix. This figure is intended for scenario analysis, not as an independently established share. Adoption is influenced by the size of the facility, availability of trained personnel, infection-control protocols, and the proportion of instruments that require chemical rather than alternative sterilization methods.
Medical Equipment and Consumables
Medical equipment and consumables manufacturers use chemical sterilization for selected devices, components, and packaged products that require validated microbial control before release. Ethylene oxide is important for compatible products requiring penetration through complex structures or packaging, while hydrogen peroxide serves suitable applications within its validated operating limits. Manufacturers evaluate product throughput, batch consistency, packaging integrity, residual requirements, and documentation throughout the production process. An illustrative planning allocation assigns approximately 30% of application demand to medical equipment and consumables. The actual proportion depends on whether contract sterilization, in-house systems, and equipment installed at manufacturing facilities are included in the market definition. Reliable qualification and change-control procedures are essential when product designs, materials, or packaging configurations change.
Pharmaceutical
Pharmaceutical applications require tightly controlled processes that protect product quality, packaging integrity, and patient safety. Chemical sterilization equipment may support selected components, manufacturing materials, or specialized processing requirements when the method is compatible with the product and validated for its intended use. Buyers place particular emphasis on documented cycle parameters, data integrity, equipment qualification, repeatability, and maintenance controls. An illustrative scenario assigns approximately 20% of the application mix to pharmaceutical operations, although this is not a verified market share. Demand depends on the product categories being manufactured, the degree of outsourced sterilization, and the use of alternative validated methods. Suppliers that can support qualification activities and maintain consistent technical documentation are better positioned to serve regulated production environments.
Food & Beverage Industry
Food and beverage operations may use specialized chemical sterilization equipment for compatible packaging, processing environments, and selected production applications. The technology must meet the relevant microbial-control objective while preserving product quality and ensuring that any chemical residues or process by-products are appropriately controlled. Equipment selection depends on the food category, packaging material, production configuration, and applicable safety requirements. An illustrative allocation of approximately 8% of modeled application demand represents this category, rather than a measured global statistic. Adoption is influenced by production scale, automation, cleaning procedures, and the suitability of chemical treatment compared with other validated methods. Food manufacturers must assess the entire process because sterilization effectiveness cannot compensate for inadequate upstream hygiene or poorly controlled packaging operations.
Others
Other applications include research laboratories, biotechnology operations, selected industrial environments, and specialized facilities requiring controlled microbial reduction or sterilization. Their equipment needs differ according to the materials being treated, contamination risks, throughput, and validation requirements. Laboratories may prioritize flexible loading configurations and cycle documentation, while specialized manufacturers may place greater emphasis on repeatability and compatibility with production workflows. An illustrative planning allocation of approximately 7% completes the application mix. This percentage is not a verified industry statistic and may change substantially when the market definition includes or excludes particular laboratory and industrial systems. Suppliers can address these customers through configurable equipment, technical consultation, maintenance services, and clear documentation of validated operating conditions.
Chemical Sterilization Equipment Market Regional Outlook
Regional demand reflects differences in healthcare investment, medical device manufacturing, pharmaceutical production, regulatory requirements, and access to technical service. North America benefits from established hospital infrastructure and a substantial base of medical technology users. Europe combines advanced healthcare systems with strong emphasis on equipment qualification and worker safety. Asia-Pacific is supported by expanding healthcare capacity and medical product manufacturing, while the Middle East and Africa present opportunities linked to hospital development and modernization of infection-prevention infrastructure. For this report, the regional market is allocated using an illustrative distribution of 32% for North America, 27% for Europe, 31% for Asia-Pacific, and 10% for the Middle East and Africa. These assumptions total 100% and should not be treated as independently verified regional measurements.
North America
North America is assigned an illustrative 32% share of the global Chemical Sterilization Equipment Market. Demand is supported by established hospital networks, medical device manufacturing, pharmaceutical operations, and the need for documented sterilization performance. Buyers evaluate equipment compatibility, cycle validation, service availability, and operator protection when modernizing sterile-processing operations. Hydrogen peroxide systems are relevant to suitable heat-sensitive instruments, while ethylene oxide continues to serve selected medical device applications. Procurement teams also consider installation requirements, ventilation, consumable availability, and the costs associated with maintaining validated processes. An internal efficiency target of 10% fewer avoidable processing delays can help evaluate workflow improvements, although actual results depend on staffing, utilization, and instrument inventory.
Europe
Europe is assigned an illustrative 27% regional share. The market is influenced by established healthcare infrastructure, medical technology manufacturing, pharmaceutical production, and attention to occupational safety and process documentation. Facilities assess chemical sterilization technologies according to validated performance, product compatibility, applicable regulatory obligations, and the availability of qualified service providers. Demand also reflects the need to manage equipment lifecycle costs and maintain reliable sterile-processing operations across diverse healthcare systems. An illustrative operational objective is to reduce avoidable equipment downtime by 10%, but results depend on maintenance practices and the age of installed systems. Buyers increasingly examine sterilant handling, emissions controls, traceability, and resource consumption alongside acquisition cost when comparing technologies.
Asia-Pacific
Asia-Pacific is assigned an illustrative 31% share, reflecting the region's combination of healthcare expansion, medical device manufacturing, pharmaceutical activity, and investment in clinical infrastructure. Demand differs substantially between mature medical technology markets and developing healthcare systems. Large hospitals and manufacturers may prioritize automated equipment, process documentation, and higher throughput, while smaller facilities can be more sensitive to installation costs and service availability. Local manufacturing capabilities can support equipment access, although advanced systems still require reliable validation support and trained operators. A modeled target of 10% improvement in equipment utilization can provide a useful internal benchmark for facilities modernizing workflows. Actual adoption depends on procurement budgets, applicable regulatory requirements, product mix, and the maturity of sterile-processing infrastructure.
Middle East & Africa
The Middle East and Africa region is assigned an illustrative 10% share of the market. Demand is shaped by hospital construction, healthcare modernization, pharmaceutical development, and efforts to strengthen infection-prevention capabilities. Larger hospitals and specialist medical facilities may require advanced low-temperature systems for compatible instruments, while other institutions may prioritize reliable core equipment, training, and accessible maintenance. Procurement can be affected by import dependence, financing constraints, uneven technical-service coverage, and the availability of qualified consumables. A practical planning objective is to reduce avoidable equipment downtime by 10%, supported by preventive maintenance and operator training. This is an internal performance target rather than a regional statistic. Long-term opportunities depend on infrastructure investment, regulatory development, and sustainable support arrangements.
List of Key Chemical Sterilization Equipment Market Companies Profiled
- STERIS
- Getinge Group
- 3M
- Advanced Sterilization Products
- Shinva Medical Instrument
- Tuttnauer
- Steelco
- Sakura Si
- HUMAN MEDITEK
- Laoken Medical
- Renosem
- Youyuan Medical Equipment
- Hanshin Medical
- MMM Group
- Hangzhou Unique Disinfection Equipment
Top Companies with Highest Market Share
- STERIS: STERIS is a prominent provider of sterilization equipment and related services, with a broad presence across healthcare and life sciences. An illustrative competitive scenario assigns the company 18% of the defined market, but this is an analytical assumption rather than a verified market-share figure.
- Getinge Group: Getinge participates in sterilization and sterile-processing equipment for hospitals and life sciences customers. An illustrative competitive scenario assigns the company 14% of the defined market; this percentage is not independently verified and should not be interpreted as a reported company result.
Investment Analysis and Opportunities in Chemical Sterilization Equipment Market
Investment opportunities are concentrated in low-temperature sterilization, equipment modernization, process monitoring, service networks, and solutions tailored to complex medical devices. Manufacturers can strengthen their position by pairing equipment sales with installation, validation assistance, operator training, preventive maintenance, and dependable consumable supply. Buyers may also consider retrofits that improve data capture or equipment monitoring when replacement of an entire system is not immediately practical. As an illustrative allocation for evaluating a potential investment portfolio, 35% could be directed toward low-temperature technology development, 25% toward automation and monitoring, 20% toward service and validation capabilities, and 20% toward regional distribution and technical support. These are hypothetical allocation assumptions, not observed industry investment shares. Investment decisions should account for product approvals, manufacturing capability, competitive differentiation, recurring service requirements, and the time needed to qualify new systems.
New Products Development
Product development is increasingly focused on compact equipment, application-specific cycles, improved monitoring, and simplified operation. Hydrogen peroxide platforms are being developed to address compatible heat-sensitive instruments and more demanding device configurations, while manufacturers continue to refine ethylene oxide equipment and associated exposure-control systems for appropriate applications. Digital interfaces, electronic records, automated loading features, and clearer maintenance diagnostics can help facilities manage operational complexity. An illustrative product-development budget could allocate 30% to process performance and validation, 25% to automation and usability, 20% to safety and environmental controls, 15% to connectivity, and 10% to serviceability. This hypothetical distribution totals 100% and does not represent measured industry spending. Successful products must demonstrate validated performance, material compatibility, safe handling, and practical lifecycle advantages. Design improvements alone cannot establish suitability for every device, load, or packaging configuration.
Recent Developments
- June 2024 – Getinge introduces Poladus 150: Getinge introduced the Poladus 150 vaporized hydrogen peroxide sterilizer for compatible heat-sensitive surgical instruments. Designed for operation at temperatures up to 55°C, the system incorporates cross-contamination barrier technology and connectivity features intended to support instrument traceability and sterile-processing workflows. The development highlights demand for specialized low-temperature equipment.
- May 2024 – Getinge introduces Lancer LSS laboratory sterilizer: Getinge presented the Lancer LSS laboratory sterilizer with connectivity, process reporting, predictive-maintenance support, energy-saving features, and configurable cycles. The product illustrates how laboratory sterilization equipment development is incorporating operational efficiency and improved control. Its relevance to the broader market lies in the increasing importance of documented, repeatable processing.
- August 2024 – Advanced Sterilization Products announces ULTRA GI Cycle clearance: Advanced Sterilization Products announced regulatory clearance for its ULTRA GI Cycle on the STERRAD 100NX system, developed for compatible duodenoscope reprocessing using hydrogen peroxide gas plasma. The development demonstrates the importance of application-specific cycle validation for complex reusable medical devices. Suitability remains dependent on the applicable instructions and compatible instruments.
- June 2025 – Solventum introduces Attest Super Rapid VH2O2 Clear Challenge Pack: Solventum introduced a challenge pack combining biological and chemical indicators for vaporized hydrogen peroxide process monitoring. Although the product is a monitoring accessory rather than a sterilizer, it reflects the wider emphasis on verification and operational assurance around chemical sterilization workflows. Monitoring tools must be used within their validated scope and according to the relevant instructions.
- September 2025 – PENTAX Medical and Advanced Sterilization Products expand duodenoscope sterilization options: PENTAX Medical and Advanced Sterilization Products announced the US launch of a sterilizable DEC duodenoscope designed for use with a compatible STERRAD hydrogen peroxide system. The development highlights collaboration between instrument manufacturers and sterilization technology providers to address reprocessing requirements for complex devices. Adoption depends on validated compatibility and the applicable operating instructions.
Report Coverage
This report examines the Chemical Sterilization Equipment Market across technology categories, end-use applications, regional markets, competitive positioning, investment priorities, and product development. The technology assessment covers ethylene oxide sterilization, hydrogen peroxide sterilization, ozone-based sterilization, formaldehyde sterilization, and other chemical approaches. Application coverage includes hospitals and clinics, medical equipment and consumables, pharmaceutical operations, food and beverage industry requirements, and other specialized users. The regional analysis considers North America, Europe, Asia-Pacific, and the Middle East and Africa, using an illustrative allocation of 32%, 27%, 31%, and 10%, respectively. These regional percentages are scenario assumptions and are not presented as independently verified market shares.
The report also considers infection-prevention requirements, demand for compatible low-temperature processing, automation, monitoring, qualification, maintenance, and operator safety. Competitive coverage includes all 15 specified companies. The two company market-share percentages, technology allocations, application allocations, operational improvement targets, and driver-contribution model are illustrative analytical assumptions, not audited market measurements. Recent developments are restricted to the specified 2024 and 2025 period. Actual purchasing and investment decisions should be based on validated equipment performance, applicable regulatory requirements, current product availability, and the intended application.
Chemical Sterilization Equipment Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 1.62 Billion in 2026 |
|
|
Market Size Value By |
USD 2.90 Billion by 2035 |
|
|
Growth Rate |
CAGR of 6.7% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Download FREE Sample
Frequently Asked Questions
-
What value is the Chemical Sterilization Equipment Market expected to touch by 2035?
The global Chemical Sterilization Equipment Market is expected to reach USD 2.90 Billion by 2035.
-
What CAGR is the Chemical Sterilization Equipment Market expected to exhibit by 2035?
The Chemical Sterilization Equipment Market is expected to exhibit a CAGR of 6.7% by 2035.
-
Who are the top players in the Chemical Sterilization Equipment Market?
Hospitals & Clinics, Medical Equipment and Consumables, Pharmaceutical, Food & Beverage Industry, Others
-
What was the value of the Chemical Sterilization Equipment Market in 2025?
In 2025, the Chemical Sterilization Equipment Market value stood at USD 1.52 Billion.
About the Author(s):
This report was authored by the Healthcare Research Team at Global Growth Insights. The team specializes in pharmaceuticals, biotechnology, medical devices, diagnostics, digital health, healthcare services, and life sciences. Their expertise includes market sizing, regulatory analysis, competitive benchmarking, and healthcare trend forecasting to support strategic investment and business growth.
Our Clients
Download FREE Sample